Mesothelioma statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of mesothelioma, 2015-2017, UK

Deaths

Deaths from mesothelioma, 2016-2018, UK.

 

Survival

Survive mesothelioma for 5 or more years, 2013-2017, England

Prevention

Preventable cases of mesothelioma, UK

  • There are around 2,700 new mesothelioma cases in the UK every year, that's more than 7 every day (2015-2017).
  • Mesothelioma is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2017).
  • In females in the UK, mesothelioma is not among the 20 most common cancers, with around 460 new cases in 2017.
  • In males in the UK, mesothelioma is the 17th most common cancer, with around 2,200 new cases in 2017.
  • Incidence rates for mesothelioma in the UK are highest in people aged 80 to 84 (2015-2017).
  • Each year almost 6 in 10 (55%) of all new mesothelioma cases in the UK are diagnosed in people aged 75 and over (2015-2017).
  • Since the early 1990s, mesothelioma incidence rates have increased by around three-fifths (61%) in the UK. Rates in females have increased by almost two times (97%), and rates in males have increased by around half (51%) (2015-2017).
  • Over the last decade, mesothelioma incidence rates have remained stable in the UK. Rates in males have remained stable, and rates in females have remained stable (2015-2017).
  • Most mesotheliomas occur in the pleura.
  • Incidence rates for mesothelioma are projected to fall by 53% in the UK between 2014 and 2035, to 3 cases per 100,000 people by 2035.
  • Mesothelioma incidence rates in England in females are similar in the most deprived quintile compared with the least, and in males are similar in the most deprived quintile compared with the least (2013-2017).
  • An estimated 2,900 people who had previously been diagnosed with mesothelioma were alive in the UK at the end of 2010.

See more in-depth mesothelioma incidence statistics

  • There are around 2,400 mesothelioma deaths in the UK every year, that's more than 6 every day (2016-2018).
  • Mesothelioma is the 20th most common cause of cancer death in the UK, accounting for 1% of all cancer deaths (2018).
  • In females in the UK, mesothelioma is not among the 20 most common causes of cancer death, with around 400 deaths in 2018.
  • In males in the UK, mesothelioma is the 15th most common cause of cancer death, with around 1,900 deaths in 2018.
  • Mortality rates for mesothelioma in the UK are highest in people aged 85 to 89 (2016-2018).
  • Each year almost 6 in 10 of all mesothelioma deaths (58%) in the UK are in people aged 75 and over (2016-2018).
  • Since the early 1970s, mesothelioma mortality rates have increased by around nine-and-a-half times (858%) in Great Britain. Rates in males have increased by more than nine-and-a-half times (872%), and rates in females have increased by around seven-and-a-half times (657%).
  • Over the last decade, mesothelioma mortality rates have increased by almost a tenth (8%) in Great Britain. Rates in males have remained stable, and rates in females have increased by a fifth (20%)
  • Mortality rates for mesothelioma are projected to fall by 46% in the UK between 2014 and 2035, to 3 deaths per 100,000 people by 2035.
  • Mesothelioma in England is not associated with deprivation.

See more in-depth mesothelioma mortality statistics

  • More than 4 in 10 (44.5%) people diagnosed with mesothelioma in England survive their disease for one year or more (2013-2017).
  • Around 5 in 100 (6.5%) people diagnosed with mesothelioma in England survive their disease for five years or more (2013-2017).
  • One-year survival for mesothelioma is higher for females than for males.
  • Mesothelioma survival in England is highest for people diagnosed aged under 50 years old (2009-2013).
  • Almost 3 in 20 men and almost a third of women in England diagnosed with mesothelioma aged 15-49 survive their disease for five years or more, compared with around 5 in 100 people diagnosed aged 80 and over (2009-2013).
  • Five-year relative survival for mesothelioma in men is below the European average in England and Scotland but similar to the European average in Wales.
  • Five-year relative survival for mesothelioma in women is below the European average in England.
  • When diagnosed at its earliest stage, around 6 in 10 (59%) people with mesothelioma will survive their disease for one year or more, compared with almost 1 in 3 (30%) people when the disease is diagnosed at the latest stage.
  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 212 UK males and 1 in 963 UK females will be diagnosed with mesothelioma in their lifetime.
  • 94% of mesothelioma cases in the UK are preventable.
  • 94% of mesothelioma cases in the UK are caused by workplace exposures.

See more in-depth mesothelioma risk statistics

  • 'Emergency presentation' is the most common route to diagnosing mesothelioma.
  • ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland, and ‘62-day wait’ is not met by any country for lung cancer.
  • ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland, and ‘62-day wait’ is not met by any country for lung cancer.

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.